Actively Recruiting
Comparison of Postoperative Analgesic Efficacy of Serratus Posterior Superior Intercostal Plane Block and Combination of Interscalene Brachial Plexus Block and Superficial Cervical Plexus Block in Shoulder Arthroscopy
Led by Ankara Etlik City Hospital · Updated on 2025-03-14
80
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the pain relief effectiveness after shoulder arthroscopy surgery by comparing two nerve block techniques: a combination of interscalene brachial plexus block and superficial cervical plexus block versus the serratus posterior superior intercostal plane block. The study aims to improve postoperative comfort and support early rehabilitation by assessing these methods in patients undergoing elective shoulder arthroscopy. This is a randomized, triple-blind intervention study led by Ankara Etlik City Hospital. The study involves two groups receiving different peripheral nerve blocks under ultrasound guidance before anesthesia and surgery. One group receives the serratus posterior superior intercostal plane block with 30 ml of 0.25% bupivacaine, while the other group has a combination of interscalene brachial plexus block (20 ml of 0.25% bupivacaine) and superficial cervical plexus block (10 ml of 0.25% bupivacaine). Both blocks are administered with detailed ultrasound techniques to ensure precise delivery. Participants will be monitored for pain scores during the first 24 hours after surgery and intraoperative remifentanil consumption. Assessments include ultrasound-guided block application, pain rating, and opioid use. The study measures how well each nerve block controls pain and reduces opioid needs to support postoperative recovery. The trial includes adults aged 18 to 65 undergoing elective shoulder arthroscopy, with follow-up during and after surgery to observe analgesic effects and safety.
CONDITIONS
Brief Title
Comparison of Postoperative Analgesic Efficacy of SPSIPB and Combination of IBPB and SCPB
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 65 years
- American Society of Anesthesiologists (ASA) physical status I, II, or III
- Body mass index between 18 and 30 kg/m2
- Scheduled for elective shoulder arthroscopy surgery
You will not qualify if you...
- Younger than 18 or older than 65 years
- ASA score IV or higher
- Advanced co-morbidities
- History of bleeding disorders
- Body mass index under 18 or over 30 kg/m2
- Patient refusal of the procedure
- Previous shoulder surgery
- Chronic opioid or analgesic use
- Emergency surgery cases
- Patients not undergoing shoulder surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants receive one of two nerve block interventions under ultrasound guidance before shoulder arthroscopy surgery to manage postoperative pain.
1 visit (in-person) on surgery day
Duration - 24 hours after surgery
Participants are monitored for pain and analgesic effectiveness during the first 24 hours after surgery.
1 follow-up visit or assessment within 24 hours
Trial Site Locations
Total: 1 location
1
Ankara Etlik City Hospital
Yenimahalle, Ankara, Turkey (Türkiye), 06170
Actively Recruiting
Research Team
M
MÜRÜVVET TAŞKIR TURAN, MD
M
MUSA ZENGİN, Associate Professor
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here